|
|
|
|
| LEADER |
01030caa a2200301 ir4500 |
| 001 |
NSK01000229748 |
| 003 |
HR-ZaNSK |
| 005 |
20070917175131.0 |
| 008 |
990215s1998 ci ||| ||eng |
| 015 |
|
|
|a HP98-5735
|2 HR
|
| 035 |
|
|
|9 (HR-ZaNSK)229991
|
| 035 |
|
|
|9 (HR-ZaNSK)990215106
|
| 035 |
|
|
|a (HR-ZaNSK)000229748
|
| 040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
| 041 |
0 |
|
|a eng
|b hrv
|
| 080 |
|
|
|a 615.014.2
|
| 100 |
1 |
|
|a Rafiee-Tehrani, Morteza
|
| 245 |
1 |
0 |
|a Formulation of theophylline controlled release tablets :
|b in vitro/in vivo and stability studies /
|c Morteza Rafiee-Tehrani, Zahra Jafari-Azar.
|
| 300 |
|
|
|b Ilustr.
|
| 504 |
|
|
|a Bibliografija: 32 jed
|
| 504 |
|
|
|a Sažetak
|
| 650 |
|
7 |
|a Lijekovi
|x Oblikovanje
|x Tablete
|2 nskps
|
| 700 |
1 |
|
|a Jafari-Azar, Zahra
|
| 773 |
0 |
|
|t Acta pharmaceutica (Zagreb)
|x 1330-0075
|g 48 (1998), 3 ; str. 155-166
|w nsk.(HR-ZaNSK)000054908
|
| 932 |
|
|
|a da
|b znanstveni rad
|
| 981 |
|
|
|p CRO
|z B9-10/98
|
| 998 |
|
|
|a iteo9902
|a sobp0001
|c sbno0008
|
| 886 |
0 |
|
|2 unimarc
|b 00783iaa2 2200229 450
|